170 Novel gene editing approach to enhance CD38-directed antitumor activity of primary human natural killer cells

• Richard Childs,
• David Allan,
• Joseph Clara,
• Emily Levy,
• Robert Reger,
• Mala Chakraborty

Affiliations

Richard Childs

6Medical Oncology Service, NCI, National Institutes of Health, MD, USA

David Allan

2Department of Medicine, University of Ottawa, Ottawa, Ontario, Canada

Joseph Clara

National Institutes of Health, Bethesda, MD, USA

Emily Levy

National Institutes of Health, Bethesda, MD, USA

Robert Reger

National Institutes of Health, Bethesda, MD, USA

Mala Chakraborty

National Institutes of Health, Bethesda, MD, USA